Figures & data
Figure 1. Histopathological analysis of pulmonary and GI tissues in rhesus monkeys challenged with SARS-CoV-2 or variants.
![Figure 1. Histopathological analysis of pulmonary and GI tissues in rhesus monkeys challenged with SARS-CoV-2 or variants.](/cms/asset/a0ec6a03-d19e-4338-89ad-06dfbe38991c/kgmi_a_2334970_f0001_oc.jpg)
Figure 2. Inflammatory responses in GI tracts post SARS-CoV-2 proto strain or variants.
![Figure 2. Inflammatory responses in GI tracts post SARS-CoV-2 proto strain or variants.](/cms/asset/3ade9beb-8355-41b0-a1bd-2815aa695edf/kgmi_a_2334970_f0002_oc.jpg)
Figure 3. Microbial beta-diversity, composition and dominant microorganisms in GI contents of SARS-CoV-2 or variants infected animals.
![Figure 3. Microbial beta-diversity, composition and dominant microorganisms in GI contents of SARS-CoV-2 or variants infected animals.](/cms/asset/d0ee1658-a1ea-46b5-82f5-7900c0f67f3b/kgmi_a_2334970_f0003_oc.jpg)
Figure 4. Prediction of microbial function and correlation analysis of tissue cytokines with microbiota in fragments of GI tract.
![Figure 4. Prediction of microbial function and correlation analysis of tissue cytokines with microbiota in fragments of GI tract.](/cms/asset/0284c9f3-f2ad-45c2-91d5-938361c45ee8/kgmi_a_2334970_f0004_oc.jpg)
Figure 5. Transcriptomic profile of fragments in GI tract post SARS-CoV-2 or variants infection.
![Figure 5. Transcriptomic profile of fragments in GI tract post SARS-CoV-2 or variants infection.](/cms/asset/92c1e019-de09-4ba0-848c-d8b4c4ba34ec/kgmi_a_2334970_f0005_oc.jpg)
Table 1. Summary of pathogenic characteristics in two clusters of SARS-CoV-2.